| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
67,945 |
64,878 |
$18.12M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
83,849 |
80,685 |
$14.20M |
| H2035 |
Alcohol and/or other drug treatment program, per hour |
43,464 |
5,119 |
$3.47M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,524 |
4,102 |
$1.47M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
4,272 |
535 |
$1.41M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,341 |
10,632 |
$933K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
15,662 |
14,172 |
$905K |
| H2012 |
Behavioral health day treatment, per hour |
6,571 |
1,225 |
$886K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
35,352 |
32,792 |
$761K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
27,801 |
24,996 |
$720K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,285 |
6,713 |
$641K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,311 |
1,188 |
$580K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
63,049 |
59,262 |
$530K |
| Q3014 |
Telehealth originating site facility fee |
13,001 |
11,569 |
$432K |
| H0001 |
Alcohol and/or drug assessment |
2,471 |
2,360 |
$418K |
| 80053 |
Comprehensive metabolic panel |
10,852 |
10,066 |
$373K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,368 |
1,252 |
$224K |
| 71046 |
Radiologic examination, chest; 2 views |
4,718 |
4,462 |
$215K |
| G0378 |
Hospital observation service, per hour |
931 |
479 |
$199K |
| 99233 |
Prolong inpt eval add15 m |
2,714 |
718 |
$195K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,911 |
3,314 |
$178K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,821 |
1,778 |
$163K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,285 |
1,259 |
$158K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,129 |
1,308 |
$146K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,390 |
443 |
$137K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
609 |
552 |
$105K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,777 |
557 |
$91K |
| 36415 |
Collection of venous blood by venipuncture |
3,810 |
2,505 |
$87K |
| 93798 |
|
1,256 |
235 |
$82K |
| 90870 |
|
374 |
110 |
$82K |
| 99223 |
Prolong inpt eval add15 m |
551 |
442 |
$75K |
| 71045 |
Radiologic examination, chest; single view |
1,104 |
1,039 |
$74K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
2,467 |
935 |
$56K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,081 |
12,862 |
$56K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,830 |
1,174 |
$53K |
| 85027 |
|
2,732 |
2,534 |
$44K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
355 |
348 |
$44K |
| 84484 |
|
8,982 |
7,118 |
$41K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
525 |
518 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
787 |
750 |
$30K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
407 |
392 |
$30K |
| J7050 |
Infusion, normal saline solution, 250 cc |
9,773 |
5,283 |
$28K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
135 |
132 |
$25K |
| 81001 |
|
3,105 |
2,859 |
$24K |
| 90834 |
Psychotherapy, 45 minutes with patient |
475 |
270 |
$21K |
| 99222 |
Initial hospital care, per day, moderate complexity |
230 |
206 |
$21K |
| 82248 |
|
4,779 |
4,490 |
$19K |
| 83690 |
|
3,959 |
3,711 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,746 |
910 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
633 |
577 |
$13K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
158 |
61 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
239 |
236 |
$10K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
80 |
66 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
209 |
142 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
57 |
52 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,649 |
3,276 |
$7K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
109 |
39 |
$7K |
| 99220 |
|
59 |
58 |
$7K |
| 84703 |
|
985 |
957 |
$7K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
112 |
106 |
$6K |
| 84145 |
|
247 |
241 |
$6K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
32 |
30 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
234 |
231 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,082 |
1,694 |
$6K |
| 99226 |
|
60 |
27 |
$5K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
149 |
77 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
449 |
321 |
$4K |
| 99221 |
|
62 |
59 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
975 |
870 |
$4K |
| 86140 |
|
745 |
727 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
82 |
79 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
197 |
196 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
519 |
409 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
1,044 |
730 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
27 |
24 |
$4K |
| 99255 |
|
26 |
26 |
$4K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
69 |
64 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
37 |
37 |
$2K |
| 99253 |
|
33 |
32 |
$2K |
| 99217 |
|
45 |
44 |
$2K |
| 96376 |
|
122 |
74 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
166 |
165 |
$2K |
| 83605 |
|
480 |
386 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
827 |
667 |
$2K |
| 85610 |
|
680 |
509 |
$2K |
| 99254 |
|
15 |
14 |
$2K |
| 82565 |
|
214 |
162 |
$1K |
| 81003 |
|
290 |
261 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
82 |
67 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
702 |
555 |
$1K |
| 59025 |
Fetal non-stress test |
15 |
12 |
$1K |
| 76820 |
|
17 |
12 |
$1K |
| 93016 |
|
66 |
66 |
$1K |
| 85379 |
|
88 |
84 |
$937.91 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
186 |
144 |
$745.61 |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
12 |
12 |
$681.85 |
| 93018 |
|
66 |
66 |
$674.48 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
788 |
765 |
$649.49 |
| 93308 |
|
35 |
29 |
$633.09 |
| 83735 |
|
203 |
132 |
$527.89 |
| 93321 |
|
92 |
87 |
$439.57 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
99 |
96 |
$437.24 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
226 |
65 |
$434.03 |
| 99152 |
|
46 |
45 |
$364.02 |
| 87081 |
|
61 |
61 |
$341.33 |
| 83880 |
|
60 |
55 |
$340.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
73 |
68 |
$308.15 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
242 |
113 |
$272.65 |
| 81025 |
|
43 |
40 |
$260.57 |
| 80306 |
|
12 |
12 |
$234.06 |
| 99497 |
|
12 |
12 |
$232.32 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
112 |
99 |
$216.03 |
| J2060 |
Injection, lorazepam, 2 mg |
28 |
24 |
$209.44 |
| 93325 |
|
92 |
88 |
$198.32 |
| J1790 |
Injection, droperidol, up to 5 mg |
31 |
30 |
$189.06 |
| 87807 |
|
27 |
26 |
$186.14 |
| 84512 |
|
13 |
12 |
$184.11 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13 |
12 |
$171.94 |
| 84702 |
|
13 |
13 |
$117.88 |
| 84132 |
|
98 |
45 |
$97.11 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
46 |
25 |
$89.55 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
28 |
27 |
$67.67 |
| 82550 |
|
12 |
12 |
$40.96 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
16 |
15 |
$23.82 |
| 84295 |
|
26 |
12 |
$19.23 |
| A9270 |
Non-covered item or service |
1,607 |
883 |
$13.98 |
| C1769 |
Guide wire |
15 |
12 |
$1.84 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
13,463 |
9,940 |
$0.57 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
29 |
13 |
$0.00 |